Group One Trading’s Eton Pharmaceutcials ETON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.61K Buy
+155
New +$4.54K ﹤0.01% 6684
2026
Q1
– Sell
-500
Closed -$8.74K – 7930
2025
Q4
$8.46K Sell
500
-262
-34% -$4.61K ﹤0.01% 6905
2025
Q3
$16.6K Buy
+762
New +$12.6K ﹤0.01% 6841
2025
Q2
– Sell
-634
Closed -$10K – 8095
2025
Q1
$8.23K Buy
+634
New +$9.58K ﹤0.01% 6386
2024
Q4
– Sell
-722
Closed -$7.32K – 7451
2024
Q3
$4.33K Buy
+722
New +$3.05K ﹤0.01% 5934
2022
Q4
– Sell
-608
Closed -$1.64K – 7460
2022
Q3
$1K Sell
608
-7,201
-92% -$17.9K ﹤0.01% 7297
2022
Q2
$20K Sell
7,809
-18,510
-70% -$62.1K ﹤0.01% 6280
2022
Q1
$115K Sell
26,319
-12,481
-32% -$49.1K ﹤0.01% 5359
2021
Q4
$166K Buy
38,800
+24,756
+176% +$118K ﹤0.01% 5260
2021
Q3
$71K Buy
+14,044
New +$73.1K ﹤0.01% 6242

Other funds holding ETON

Group One Trading's ETON Position: Q2 2026 in Review

Group One Trading opened a new position in Eton Pharmaceutcials (ETON) in Q2 2026: 155 shares worth $5.61K. The stake represents ﹤0.01% of the portfolio and ranks #6684 among its holdings. This is a return to the name: Group One Trading previously reported a position in ETON as recently as Q4 2025.

Group One Trading first reported a position in ETON in Q3 2021 and has held it in 10 quarters since. The position peaked at $166K in Q4 2021. 164 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • Group One Trading held 155 shares of Eton Pharmaceutcials worth $5.61K as of Q2 2026.
  • Eton Pharmaceutcials was a new Group One Trading position in Q2 2026.
  • Eton Pharmaceutcials made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #6684 holding.
  • Group One Trading first reported a position in Eton Pharmaceutcials in Q3 2021 and has held it in 10 quarters since.
  • Group One Trading's Eton Pharmaceutcials position peaked at $166K in Q4 2021.
  • 164 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.